Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$191.17 - $325.63 $25.3 Million - $43.1 Million
132,304 Added 157.48%
216,318 $70.4 Million
Q4 2023

Feb 14, 2024

BUY
$160.99 - $215.69 $13.5 Million - $18.1 Million
84,014 New
84,014 $16 Million
Q2 2023

Aug 14, 2023

SELL
$223.05 - $302.68 $12.2 Million - $16.5 Million
-54,525 Reduced 53.0%
48,346 $13.8 Million
Q1 2023

May 15, 2023

BUY
$175.41 - $217.92 $12.3 Million - $15.3 Million
70,265 Added 215.5%
102,871 $22.3 Million
Q4 2022

Feb 14, 2023

BUY
$204.38 - $296.82 $6.49 Million - $9.43 Million
31,760 Added 3754.14%
32,606 $6.7 Million
Q3 2022

Nov 14, 2022

BUY
$195.21 - $310.53 $165,147 - $262,708
846 New
846 $235,000
Q4 2021

Feb 14, 2022

SELL
$165.13 - $241.83 $11.4 Million - $16.7 Million
-69,253 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$163.99 - $235.57 $7.77 Million - $11.2 Million
47,369 Added 216.45%
69,253 $14.3 Million
Q2 2021

Aug 16, 2021

SELL
$131.45 - $201.49 $5.47 Million - $8.39 Million
-41,638 Reduced 65.55%
21,884 $4.15 Million
Q1 2021

May 17, 2021

BUY
$92.73 - $142.05 $5.89 Million - $9.02 Million
63,522 New
63,522 $8.27 Million
Q4 2020

Feb 16, 2021

SELL
$67.44 - $103.72 $2.93 Million - $4.5 Million
-43,383 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$42.79 - $75.8 $9.63 Million - $17.1 Million
-225,106 Reduced 83.84%
43,383 $3.29 Million
Q2 2020

Aug 14, 2020

BUY
$27.25 - $47.53 $845,894 - $1.48 Million
31,042 Added 13.07%
268,489 $12.7 Million
Q1 2020

May 15, 2020

SELL
$23.16 - $47.74 $2.83 Million - $5.83 Million
-122,172 Reduced 33.97%
237,447 $7.88 Million
Q4 2019

Feb 14, 2020

BUY
$29.4 - $44.98 $10.6 Million - $16.2 Million
359,619 New
359,619 $15.8 Million

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.